ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Volker Wiederrich | 39,79 | 39,79 | 2024-03-26 |
| Niclas Kappelin | 26,05 | 26,05 | 2024-03-26 |
| Derek Simmross | 25,95 | 25,95 | 2024-03-26 |
| Tomi Kalevi Heikkinen | 0,33 | 0,33 | 2024-03-26 |
| Kyösti Antero Tuuli | 0,33 | 0,33 | 2024-03-26 |
| Siv Merethe Skorpen | 0,32 | 0,32 | 2024-03-26 |
| Erlend Skorpen | 0,32 | 0,32 | 2024-03-26 |
| Per Herseth | 0,25 | 0,25 | 2024-03-26 |
| Tommy Andersson | 0,17 | 0,17 | 2024-03-26 |
| Nordnet Pensionsförsäkring | 0,16 | 0,16 | 2024-03-26 |
2024-05-30 Delårsrapport 2024-Q3
2024-08-29 Bokslutskommuniké 2024
